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The molluscum contagiosum virus (MCV) MC159 protein contains two death effector domains (DEDs) that bind to the DEDs
of caspase-8 and FADD and inhibit apoptosis. We constructed MC159 truncation mutants and found that the amino-terminal
region before the first DED and nearly all the carboxyl terminus after the second DED were dispensable for the antiapoptotic
activity of MC159. We also engineered tandem repeats of two identical MC159 DEDs, MC159 DEDs in the reverse orientation,
and MC159-caspase-8 chimeras in which a DED of MC159 was replaced with the corresponding DED of caspase-8. Each of
these constructs bound to caspase-8, but was unable to bind to FADD or block apoptosis. In addition, we constructed mutants
containing only a single DED of MC159. These mutants bound to both FADD and caspase-8, but could not block apoptosisINTRODUCTION
Apoptosis is a host defense mechanism that destroys
virus-infected cells. Viral inhibition of apoptosis may al-
low virus-infected cells to survive long enough to pro-
duce new virions. Many DNA viruses encode proteins
that block apoptosis induced through death receptor
pathways (Locksley et al., 2001). Ligands such as TNF
and Fas ligand bind to their respective receptors TNFR
and Fas to initiate death receptor signaling (Peter et al.,
1999). Ligand binding results in recruitment of the
adapter molecule Fas-associated death domain (FADD)
to the death receptor. Caspase-8 (formerly known as
FLICE) is then recruited to form a complex known as the
death-inducing signaling complex (DISC). When
caspase-8 is recruited to the DISC, it is cleaved to its
active form and subsequently cleaves other downstream
effector caspases, resulting in apoptosis (Medema et al.,
1997; Muzio et al., 1996).
Viruses have developed methods to block Fas and
TNFR signaling. Adenovirus encodes the E3-10.4/14.5K
proteins that internalize and degrade Fas (Tollefson et
al., 1998). The myxoma virus encodes secreted and in-
tracellular forms of the M-T2 protein that function as
TNFR homologs. The secreted form binds to TNF and
1 Supplementary data for this article is available on Ideal.
2 Current address: Millennium Pharmaceuticals, Inc., Cambridge, MA
02139.
3 To whom correspondence and reprint requests should be ad-217blocks its ability to bind to the receptor, while the intra-
cellular form blocks signaling through the receptor
(Schreiber et al., 1997). Cowpox virus encodes four pro-
teins known as crmB, crmC, crmD, and crmE, which
block TNF activity (Hu et al., 1994; Loparev et al., 1998;
Reading et al., 2002; Saraiva and Alcami, 2001; Smith et
al., 1996). Other viral proteins block apoptosis by inhib-
iting the activity of caspases. The adenovirus 14.7K pro-
tein interacts with caspase-8 to block its activity (Chen et
al., 1998), while cowpox encodes the crmA protein that
inhibits activated caspase-8. Baculovirus expresses the
p35 and the inhibitor of apoptosis protein (IAP) that
inhibit caspases that are downstream of caspase-8 (De-
veraux and Reed, 1999; Miller, 1997).
Several viruses encode a class of apoptotic inhibitors
known as viral FLICE-inhibitory proteins (v-FLIPs), which
are homologs of the cellular FLIPs (Irmler et al., 1997),
and are thought to block apoptosis by interfering with the
ability of caspase-8 to bind to FADD. v-FLIPs are en-
coded by several gamma herpesviruses and by the hu-
man poxvirus molluscum contagiosium (MCV). Five v-
FLIPs, MCV MC159, equine herpesvirus-2 (EHV-2) E8,
herpesvirus saimiri (HVS) ORF16, bovine herpesvirus-4
(BHV-4) E2, and Kaposi’s sarcoma associated herpesvi-
rus (KSHV) K13 have been shown to block apoptosis
mediated by death receptors (Bertin et al., 1997; Djerbi et
al., 1999; Hu et al., 1997a; Medema et al., 1999; Thome et
al., 1997; Wang et al., 1997).
v-FLIPs contain two death effector domains (DEDs)
that are homologous to the DEDs of FADD andor the formation of death effector filaments. Thus, the DED
or with those of caspase-8.
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caspase-8. The DEDs of the v-FLIPs can bind to the
DEDs of FADD and caspase-8. Both the MCV MC159 ands of M0042-6822/02
the EHV-2 E8 v-FLIP proteins are found in a complex with
the activated Fas receptor (Shisler and Moss, 2001;
Thome et al., 1997). Furthermore, E8 v-FLIP may prevent
the activation of caspase-8 by blocking its recruitment to
the DISC (Thome et al., 1997). Although these studies
suggest that the v-FLIPs block apoptosis through the
interaction of their DEDs with those of FADD and
caspase-8, the role of the individual v-FLIP DEDs is not
known. To determine whether each of the DEDs is nec-
essary for the antiapoptotic activity of MCV MC159 v-
FLIP, we constructed a series of mutant proteins contain-
ing different combinations of the MC159 DEDs as well as
the MC159 and caspase-8 DEDs. We show that both
DEDs from a v-FLIP, in their proper order, are required to
block apoptosis and that a DED from the proapoptotic
caspase-8 cannot functionally substitute for a DED of
MC159.
RESULTS
The N-terminal 15 amino acids and nearly all of the
region after the second DED of MC159 are
dispensable for the antiapoptotic activity of MC159
Comparison of the sequence of MC159 with that of the
FADD DED (Eberstadt et al., 1998) predicts that MC159
encodes a 241 amino acid protein containing a 6 amino
acid N-terminal region followed by a 74 amino acid DED,
a 14 amino acid linker region, an 83 amino acid DED, and
a 64 amino acid carboxyl-terminal tail (Fig. 1). Amino- and
carboxyl-terminal truncation mutants were constructed
and analyzed in the HeLa cell death assay to determine
which portions of the termini of MC159 are required for
its antiapoptotic activity. Deletion of the first 15 amino
acids of the protein (MC159N15), which includes nine
amino acids of the first DED, had little effect on the ability
of the MC159 protein to protect against Fas- and TNF-
induced apoptosis (Figs. 1 and 2). Deletion of 62 amino
acids from the carboxyl-terminus of MC159 (MC159C62)
did not significantly reduce the ability of MC159 to block
Fas- and TNF-induced apoptosis. However, deletion of
71 amino acids from the carboxyl-terminus of the protein
(MC159C71), which includes the last seven amino acids
of the second DED, resulted in complete loss of the
antiapoptotic activity of MC159 (Figs. 1 and 2). The amino-
terminal mutant MC159N15 was expressed on immuno-
blot (Fig. 2). Carboxyl-terminal mutants MC159C62 and
MC159C71 were epitope tagged with hemagglutinin an-
tigen (HA) and expression was verified by immunoblot
(Fig. 2). Thus, the amino-terminus before the first DED
and nearly all of the carboxyl-terminus after the second
FIG. 1. Wild-type and mutant MC159 constructs. Top line shows the structure of wild-type MC159. Numbers above MC159WT refer to the amino
acid positions of the DED domains. The location of the MC159 deletion mutants is shown below MC159WT. The number designates the number of
amino acids deleted from the amino- (N) or carboxy- (C) terminal region of the protein. Each of the mutant constructs was derived from MC159R5
(except MC159A and MC159B), which has two amino acid substitutions denoted by the asterisk at the beginning of the second DED. Black boxes
indicate the amino terminus, linker region, and carboxyl-terminus of MC159.
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DED are dispensable for the antiapoptotic activity of
MC159.
Both MC159 DEDs, in their proper order, are required
for protection from Fas- and TNF-induced apoptosis
To determine the importance of the two DEDs and
their arrangement in the protein, we constructed plas-
mids expressing different combinations of the MC159
DEDs (Fig. 1). Transfection of HeLa cells with each of the
MC159 DED substitution and single DED mutants
showed that each of the proteins was expressed in the
cytoplasm of the cell in a similar pattern to that seen with
wild-type MC159 (unpublished data). Plasmids express-
ing a single DED of MC159 (MC159A or MC159B) or
MC159 mutants containing different combinations of the
two DEDs (MC159AA, MC159BB, or MC159BA) (Fig. 1)
were tested for their ability to protect against Fas- and
TNF-induced apoptosis in HeLa cells. A single DED of
MC159 and MC159 mutants that contained two identical
DEDs or the two different DEDs in the reverse order were
unable to protect against Fas- and TNF-induced apopto-
sis (Fig. 3). Thus, two DEDs are necessary for the anti-
apoptotic activity of MC159 and one MC159 DED cannot
substitute for another. Furthermore, the order of the
DEDs is critical for the function of MC159.
The DEDs of caspase-8 cannot functionally substitute
for a DED of MC159
To determine whether the DEDs of caspase-8 can
replace a DED of MC159 and still block apoptosis, we
constructed chimeric plasmids expressing combinations
of the MC159 and caspase-8 DEDs (C8A-MC159B and
MC159A-C8B) (Fig. 1). Both chimeric proteins were ex-
pressed in the cytoplasm of transfected cells similar to
wild-type MC159 (unpublished data). Both of the chime-
ras containing MC159 and caspase-8 DEDs were unable
to protect against Fas- and TNF-induced apoptosis in
HeLa cells (Fig. 3). Thus, the DEDs of caspase-8 cannot
functionally replace the DEDs of MC159.
The EcoRV site introduced into MC159 to produce
MC159R5, the DED substitution mutants, and MC159-
caspase-8 chimeras results in a change in the first two
amino acids of the second DED—R95D and Y96I (Fig. 1).
Both the wild-type MC159 and mutant MC159R5 con-
structs protected HeLa cells from Fas- and TNF-induced
apoptosis (Fig. 3). However, unlike wild-type MC159, the
FIG. 3. Antiapoptotic activity of MC159 DED substitution, MC159-
caspase-8 chimera, and single DED mutants. HeLa cells were trans-
fected (described in the legend to Fig. 2), treated with anti-Fas antibody
or TNF, and percentage cell death was determined. Values represent
the average of at least two separate experiments.
FIG. 2. (A) Antiapoptotic activity of amino and carboxyl-terminal
truncation mutants of MC159. HeLa cells were cotransfected with the
indicated plasmid and a plasmid expressing -galactosidase and
treated with anti-Fas antibody or TNF. Percentage cell death was
calculated as defined under Materials and Methods. MC159 com-
pletely protected against TNF treatment resulting in 0% cell death. In
some cases values of greater than 100% cell death were obtained due
to increased cell death with certain MC159 mutants relative to vector,
and normalization of all the values to the level of cell death with vector
set at 100%. Values represent the average of two separate experiments.
(B) Expression of MC159 amino- and carboxyl-terminal truncation mu-
tants. 293T cells were transfected with 3.2 g of the plasmids express-
ing MC159N15 and MC159C71-HA and 0.8 g of vector (pCI), MC159,
MC159-HA, and MC159C62-HA to obtain similar levels of expression.
The carboxyl-terminal truncation mutants were epitope tagged with HA
to analyze their expression levels since the epitope that the MC159
antibody recognizes was deleted. The cells were lysed and immuno-
blotted with either anti-MC159 polyclonal rabbit antiserum for the
amino-terminal truncation mutant or anti-HA antibody for the carboxyl-
terminal truncation mutants. The expression levels of the amino-termi-
nal MC159N15 (left) and carboxyl-terminal MC159C62-HA and
MC159C71-HA (right) truncation mutants are shown. MC159C71 was
unable to protect against apoptosis when transfected at four times the
concentration of wild-type MC159 (data not shown).
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MC159R5 mutant was unable to protect Jurkat cells from
Fas- and TRAIL-induced apoptosis (Fig. 4). Thus, the first
two amino acids of the second DED of MC159 may be
important for protection against apoptosis mediated by
Fas and TRAIL in Jurkat cells. These results extend our
previous findings that a mutation in a DED of MC159 can
protect against apoptosis in HeLa cells, but not in Jurkat
cells (Garvey et al., 2002).
Inhibition of FADD death effector filament formation
requires both MC159 DEDs
Death effector filaments are formed by high-level ex-
pression of DED-containing proteins such as FADD and
the prodomain of caspase-8. The oligomerization of
these proteins results in the formation of cytoplasmic
filaments, which recruit and activate caspases to cause
apoptosis. MC159 blocks formation of FADD death effec-
tor filaments. Each of the MC159 mutants was examined
for their ability to inhibit the formation of FADD death
effector filaments. Although MC159R5 blocks apoptosis
induced by Fas and TNF in HeLa cells, MC159R5 was
unable to block the formation of death effector filaments
(Fig. 5). As expected, the DED substitution and the
MC159-caspase-8 chimera mutants, which are derived
from the MC159R5 construct, were also unable to block
the formation of these filaments (data not shown). In
addition, the single DED mutants (MC159A and
MC159B), which were not derived from MC159R5, failed
to block death effector filament formation (Fig. 5), Thus,
two DEDs of MC159 are necessary for inhibition of death
effector filament formation.
Binding of an MC159 DED to caspase-8 is insufficient
to protect against death receptor induced apoptosis
Immunoprecipitation and immunoblotting experiments
were performed to determine which DEDs are required
for MC159 binding to FADD or caspase-8. Each of the
DED substitution mutants lost the ability to bind FADD
and showed reduced binding to caspase-8 (Fig. 6). The
C8A-MC159B chimera failed to bind FADD and showed
decreased binding to caspase-8, whereas the MC159A-
C8B chimera showed weak binding to FADD, but main-
FIG. 5. MC159R5, MC159A, and MC159B are unable to block forma-
tion of FADD death effector filaments. HeLa cells were cotransfected
with FADD-GFP and wild-type MC159, MC159R5, MC159A, or MC159B,
stained with anti-MC159 polyclonal rabbit antiserum followed by Texas
red-conjugated anti-rabbit IgG antibody, and visualized by fluorescence
microscopy at 1000 magnification. (A) FADD-GFP expression in
green. (B) MC159 expression in red. The experiment was done three
times and a representative result is shown.
FIG. 4. Antiapoptotic activity of an MC159 mutant containing amino
acid substitutions at the beginning of the second DED. Jurkat cells
were cotransfected with the indicated plasmid and a plasmid-express-
ing green fluorescent protein (GFP). Transfected Jurkat cells were
treated with anti-Fas antibody or TRAIL, stained with annexin-V-PE, and
analyzed by flow cytometry for GFP and annexin-V-PE-positive cells.
The percentage apoptosis was determined by the percentage of an-
nexin-V-positive cells in the GFP-positive population. The experiment
was repeated with the same result.
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tained the ability to bind to caspase-8. Therefore, the lack
of antiapoptotic activity by the MC159A-C8B chimera
indicates that binding to caspase-8 is not sufficient to
block apoptosis. The loss of antiapoptotic activity of the
DED substitution and the C8A-MC159B chimera mutants
may be due to their inability to bind FADD. In contrast,
MC159 constructs containing a single DED lost their
antiapoptotic activity, but bound to both FADD and
caspase-8 (Fig. 7). These results suggest that both DEDs
may need to bind cooperatively for the protein to main-
tain its antiapoptotic function.
DISCUSSION
We have shown that the DEDs of the MC159 v-FLIP are
not functionally interchangeable and that nearly all of the
amino- and carboxyl-termini before and after the DEDs
are not required to block apoptosis. Deletion of 62 amino
acids from the carboxyl-terminus of MC159 did not alter
the antiapoptotic activity of the protein. MC159 contains
a 64 amino acid carboxy tail after the second DED; in
contrast, the other v-FLIP proteins contain much shorter
carboxy tails. The EHV-2 E8 and HVS ORF71 proteins
have no amino acids after their second DED, while
BHV-4 BORFE2 has a 9 amino acid tail and KSHV K13 has
a 17 amino acid tail. Thus, although MC159 has a large
carboxy tail after its second DED, this portion of the
protein is not required for its antiapoptotic activity. This
region of MCV MC159 may have an additional function
such as interaction with other molecules in certain cell
types. MCV establishes a persistent infection in epider-
mal cells, while the other v-FLIPs are expressed in
gamma herpesviruses, which are latent in lymphoid
cells.
v-FLIPs may be derived from their cellular counter-
parts, the cellular FLIPs, which also contain two DEDs.
Some studies have shown that c-FLIPs bind to both
FADD and caspase-8 (Shu et al., 1997; Srinivasula et al.,
1997), while other studies (Hu et al., 1997b; Inohara et al.,
1997) detected binding only to caspase-8. Furthermore,
the critical activity of c-FLIP at the DISC appears to be
the ability to bind to caspase-8 and block its further
recruitment and activation (Scaffidi et al., 1999). In our
experiments, each of the DED substitution (MC159AA,
MC159BB, and MC159BA) and chimera mutants (C8A-
MC159B and MC159A-C8B) was able to bind partially to
caspase-8, but lost the ability to bind FADD and block
apoptosis.
The MC159 constructs containing an individual DED
were able to bind to both FADD and caspase-8, but did
not have antiapoptotic activity. The ability of the single
DED constructs to bind to FADD, while the DED substi-
tution mutants were unable to bind FADD, may be the
result of an inaccessible binding site caused by the
inappropriate folding of the substitution mutants be-
cause of the incorrect DED. Our present findings con-
trast in some respects, but agree in other respects with
those of a study by Tsukumo and Yonehara (1999). Unlike
our study, Tsukumo and Yonehara found that constructs
containing individual DEDs of MC159 failed to bind to
either FADD or a construct containing only the two DEDs
of caspase-8. One explanation for the difference under
Results is that our study assessed binding to full-length
FADD and caspase-8 expressed in mammalian cells,
while the former study evaluated binding of FADD or
caspase-8 fusion proteins using a yeast two-hybrid sys-
tem. A second difference in the two studies is that Tsu-
kumo and Yonehara expressed only the single DED of
FIG. 6. Binding of MC159 DED substitution and chimera mutants to
FADD and caspase-8. Human embryonic kidney 293T cells were
cotransfected with either (A) FADD or (B) caspase-8-GFP and the
indicated MC159 plasmid. Transfected 293T cells were lysed, im-
munoprecipitated with anti-MC159 polyclonal rabbit antiserum, and
immunoblotted with either anti-FADD or anti-GFP monoclonal anti-
body. The top panel in each figure shows binding of the MC159
mutants to either FADD (A) or caspase-8 (B) and the middle and
bottom panels show the expression levels in the lysates. The ex-
periment was done three times with similar results and a represen-
tative result is shown.
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MC159 fused to a yeast protein, while we expressed
each single DED preceded by the amino terminal region
and followed by the carboxyl-terminal tail of MC159. Both
our study and that of Tsukumo and Yonehara found that
the MC159 constructs containing individual DEDs could
not protect from Fas-mediated apoptosis.
The single MC159 DED mutants failed to block forma-
tion of FADD death effector filaments, although they were
able to bind to FADD. The inability to block formation of
these filaments suggests that MC159 requires two DEDs
to inhibit formation of death effector filaments. This result
is consistent with our prior finding that a specific motif
(RXDL) in both DEDs is needed for blocking filament
formation (Garvey et al., 2002). The loss of antiapoptotic
activity and the inability to block death effector filament
formation in both the single DED and the DED substitu-
tion mutants suggests that the two MC159 DEDs act
cooperatively to perform their multiple functions.
The two chimeric mutants in which an individual DED
of MC159 was replaced with a corresponding DED of
caspase-8 bound to caspase-8, but lost almost all of their
ability to bind FADD and were unable to block apoptosis.
Tsukumo and Yonehara (1999) made chimeras between
MC159 and the DEDs of caspase-8 that bound both to
FADD and to the prodomain of caspase-8 in a yeast
two-hybrid system and were able to partially block Fas-
mediated apoptosis. Our constructs retained the entire
structure of MC159 and replaced only individual DEDs of
MC159 with the corresponding DED of caspase-8, while
Tsukumo and Yonehara constructed chimeras in which
they split the MC159 and caspase-8 DED molecules in
half and ligated them. Thus, the differences under Re-
sults in the two studies may reflect the differences in the
constructs.
In summary, using a series of MC159 mutants, we
have shown that the DEDs of MC159 are not functionally
interchangeable with each other or with those of
caspase-8. These findings indicate that both DEDs act
together in a coordinated fashion to bind FADD and
caspase-8, block formation of death effector filaments,
and inhibit death receptor mediated apoptosis.
MATERIALS AND METHODS
Plasmids
MCV 159L was cloned into the pCI expression plasmid
(Promega, Madison, WI) as described previously (Bertin
et al., 1997). An MC159 amino-terminal deletion mutant
was produced by PCR using primer MC159N15 and
primer MC159C-XbaI with pCI-MC159 (Table 1, Supple-
mental Data 2002). MC159N15 results in deletion of
amino acids 2 to 15 from the amino-terminus of the
protein. Carboxy-deletion mutants were generated
by PCR using primer MC159N-EcoRI and primers
MC159C28, MC159C50, MC159C62, MC159C71, or
MC159C82 with pCI-MC159 (Table 1, Supplemental Data
2002). The number following the C in the primer indicates
the number of amino acids deleted from the carboxyl-
terminus of MC159. Each PCR product was cut with
EcoRI and XbaI and cloned into the corresponding sites
of pCI.
The MC159A plasmid was constructed by PCR using
three separate reactions as part of the SOEing proce-
dure (Horton et al., 1990). First, DED-A (amino acids 1 to
79) was obtained by PCR of pCI-MC159 using primers
MC159N-EcoRI and MC159AA-Reverse-b. Next the DNA
encoding the carboxy tail of MC159 (amino acids 176 to
241) was amplified by PCR using primers MC159AA-
Forward-c and MC159AA-Reverse-d and plasmid pCI-
MC159. The first two PCR products were annealed and
FIG. 7. Binding of single MC159 DEDs to FADD and caspase-8. Human embryonic kidney 293T cells were cotransfected with either (A) FADD or
(B) caspase-8-GFP and the indicated MC159 plasmid. 293T cells were lysed, immunoprecipitated, and immunoblotted (described in the legend to Fig.
6). The top panel demonstrates binding to either FADD (A) or caspase-8 (B) and the middle and bottom panels show the expression levels in the
lysates. A small amount of FADD and caspase-8-GFP (A and B, lane 3) is present after immunoprecipitation with anti-MC159 polyclonal rabbit serum.
This is presumably due to incomplete washing of the immunoprecipitates. The data are representative of an experiment that was performed two times
with the same result.
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amplified using primers MC159N-EcoRI and MC159AA-
Reverse-d followed by cloning into the EcoRI and NotI
sites of pCI. MC159B was obtained by PCR with primers
MC159-NDEDB and MC159AA-Reverse-d primers and
plasmid pCI-MC159 and cloned into the EcoRI and NotI
sites of pCI.
The MC159R5 plasmid contains an EcoRV site substi-
tuted for codons 95 and 96 of MC159 and was con-
structed by PCR in three separate reactions using
the SOEing procedure. Primers MC159N-EcoRI and
MC159R5 were used with plasmid pCI-MC159 to amplify
the DNA encoding the amino half of MC159, and primers
MC159R5-Reverse and MC159C-XBA were used with
plasmid pCI-MC159 to amplify the DNA encoding the
carboxy half of MC159. The two PCR products were
annealed and amplified using primers MC159N-EcoRI
and MC159C-XBA and the resulting PCR product was
cloned into the EcoRI and XbaI sites of pCI.
The MC159 DED substitution and MC159-caspase-8
chimera mutants were all derived from MC159R5 using
the SOEing procedure. MC159AA was constructed by
PCR in three reactions. The first reaction used primers
MC159AA-Forward-a and MC159AA-Reverse-b with
plasmid pCI-MC159R5 to generate the DNA sequence
for DED-A. The second reaction used primers MC159AA-
Forward-c and MC159AA-Reverse-d with plasmid pCI-
MC159 to generate the DNA sequence for the carboxy
tail. The third reaction used annealed PCR products from
the first two reactions and primers MC159AA-Forward-a
and MC159AA-Reverse-d to generate a PCR product
containing the DNA sequence for DED-A followed by the
carboxy tail. The PCR product was cut with EcoRV and
NotI and cloned into the corresponding sites of
MC159R5. MC159BB was constructed by PCR using
primers MC159BB-Forward and 159BB-Reverse with
plasmid pCI-MC159R5. The PCR product was cut with
EcoRI and EcoRV and cloned into the corresponding
sites of MC159R5. MC159BA was produced by excising
DED-A from the MC159AA construct with EcoRV and NotI
and inserting it into the corresponding sites of MC159BB.
The caspase-8-R5 expression vector contains the
prodomain of caspase-8 with an EcoRV site substituted
for codons 88 and 89 in the linker region between the
two DEDs and was constructed with the SOEing tech-
nique. Primers caspase-8N-EcoRI and caspase-8-R5
were used with a plasmid containing caspase-8 to am-
plify the DNA sequence for the amino half of the
caspase-8 prodomain, and primers caspase-8-R5-Re-
verse and caspase-8C-XBA were used with the
caspase-8 plasmid to amplify the DNA sequence for the
carboxy half of the caspase-8 prodomain. The two PCR
products were annealed and amplified using primers
caspase-8N-EcoRI and caspase-8C-XBA and the result-
ing PCR product was cloned into the EcoRI and XbaI
sites of pCI.
C8A-MC159B was constructed by excising DED-A of
caspase-8 from plasmid pCI-caspase-8-R5 with EcoRI
and EcoRV and inserting it into the same sites of plasmid
pCI-MC159R5. MC159A-C8B was produced by first cut-
ting the DED-B of caspase-8 from plasmid caspase-8-R5
with EcoRV and NotI and inserting it into the correspond-
ing sites of plasmid pCI-MC159R5. The DNA sequence of
the two DEDs in the plasmid was amplified by PCR using
primers MC159N-EcoRI and C8BW-Reverse. The DNA
encoding the carboxyl-terminus of MC159 was gener-
ated by PCR using plasmid pCI-MC159 and primers
MC159AA-Forward-c and MC159-Reverse-d. The two
PCR products were annealed and PCR was performed
using primers MC159N-EcoRI and MC159AA-Reverse-d.
The PCR product was cut with EcoRI and NotI and
cloned into the same sites of pCI to generate MC159A-
C8B. The MC159 and caspase-8 sequences in each
plasmid were determined for each of the mutants to
verify that no unexpected mutations were introduced
during PCR.
HeLa cell death assay
HeLa cells were cotransfected with plasmids express-
ing -galactosidase and either pCI, pCI-MC159, or pCI-
MC159 mutants at a 1:2 ratio using LipofectAMINE (In-
vitrogen, Carlsbad, CA). At 28 h after transfection, cells
were treated with either 500 ng/ml anti-human Fas mAb
CH11 (Kamiya Biochemical, Seattle, WA) and 5 g/ml
cycloheximide or 20 ng/ml recombinant (Escherichia
coli) human TNF- (Roche, Indianapolis, IN) and 15
g/ml cycloheximide for 16 h. Control cells received
cycloheximide alone. Serial dilutions of anti-Fas antibody
and TNF- were tested to determine the concentrations
used in this assay. Cells were fixed and stained for
-galactosidase expression (Garvey et al., 2002). The
number of flat, blue staining cells in five random fields of
view was counted. Protection from Fas- and TNF-in-
duced apoptosis was defined as the ratio of the number
of flat, blue staining cells in treated-to-control wells. All
values were normalized to the empty vector value. Nor-
malized percent protection was defined as percent pro-
tection with MC159 minus percent protection with empty
vector. Percent cell death was defined as 100% minus
normalized percent protection.
Jurkat cell death assay
Jurkat cells were transfected with 2.5 g of pEGFP-N1
(Clontech Laboratories, Inc., Palo Alto, CA) and 10 g of
pCI, pCI-MC159, or pCI-MC159R5 as described previ-
ously (Garvey et al., 2002). At 30 h after transfection, the
cells were treated with 100 ng/ml anti-human Fas mono-
clonal antibody APO-1 (Kamiya Biochemical) and 5%
soluble protein A (Sigma, St. Louis, MO) or 100 ng/ml
TRAIL and 2 g/ml enhancer antibody (Alexis, San Di-
ego, CA) for 12 h. Control samples were treated with
soluble protein A or enhancer antibody only. Serial dilu-
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tions of anti-Fas antibody and TRAIL were tested to
determine the concentrations used in this assay. At 12 h
after treatment, the cells were stained with annexin-V-
phycoerythrin (PE) (BD Pharmingen, San Diego, CA) and
analyzed by flow cytometry for GFP and annexin-V-PE-
positive cells. Percent apoptosis was defined by the ratio
of annexin-V-positive cells to GFP-transfected cells.
Immunoprecipitation and immunoblotting
293T cells were transfected with pCI, pCI-MC159, or
mutant pCI-MC159 and a plasmid expressing either
FADD or caspase-8-GFP (Siegel et al., 1998) using Fu-
gene-6 (Roche, Indianapolis, IN). The amount of pCI-
MC159 mutant DNA transfected was varied so that ex-
pression of the mutant proteins was equivalent to wild-
type MC159. Cells were lysed 24 h after transfection as
described previously (Garvey et al., 2002).
For immunoprecipitations, 100 l lysate was absorbed
with 5 l of normal rabbit serum and nonspecific com-
plexes were removed with protein A-Sepharose (Sigma).
Lysates were then incubated with 3 l anti-MC159 poly-
clonal rabbit serum (a kind gift from Joanna Shisler),
followed by protein A-Sepharose. After four washes in
lysis buffer, the samples were resuspended in SDS load-
ing buffer and boiled. Lysates and immunoprecipitations
were analyzed by immunoblotting using anti-FADD
monoclonal antibody (Signal Transduction Laboratories,
Lexington, KY), anti-GFP monoclonal antibody (Roche), or
anti-MC159 polyclonal rabbit antiserum. The blots were
then treated with either donkey anti-mouse IgG horse-
radish peroxidase (HRP) antibody (Jackson Immuno-
Research Laboratories, Inc., West Grove, PA) or anti-
rabbit IgG HRP antibody and proteins were detected with
SuperSignal chemiluminescent substrate (Pierce Chem-
ical Co., Rockford, IL).
Immunofluorescence
HeLa cells on glass coverslips were transfected with
0.5 g pFADD-GFP (Siegel et al., 1998) and 1.5 g pCI-
MC159 or pCI-MC159 mutants for the death effector
filament assay using Superfect (Qiagen Inc., Chatsworth,
CA). The cells were incubated with 1 g/ml Hoechst Dye
(Sigma) at 16–24 h after transfection for 30 min at 37°C
to label the nuclei. Cells were fixed with 100% methanol,
treated with anti-MC159 polyclonal rabbit antiserum fol-
lowed by donkey anti-rabbit Texas red IgG antibody
(Jackson ImmmunoResearch) and examined with an Ax-
iophot microscope at 1000 magnification (Carl Zeis
Inc., Thornwood, NY).
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